Wu, Hao <br/><br/>
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.  [electronic resource] 

 -  Nature medicine  Jul 2017 
 - 850-858 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1546-170X 
<br/><br/><label>Standard No.: </label>10.1038/nm.4345  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bile Acids and Salts--metabolism<br/>DNA, Bacterial--analysis<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Double-Blind Method<br/>Fatty Acids, Volatile--metabolism<br/>Fecal Microbiota Transplantation<br/>Feces--chemistry<br/>Female<br/>Gastrointestinal Microbiome--genetics<br/>Germ-Free Life<br/>Glucose Tolerance Test<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>In Vitro Techniques<br/>Male<br/>Metagenomics<br/>Metformin--therapeutic use<br/>Mice<br/>Middle Aged